Inhibition of histone deacetylases sensitizes EGF receptor-TK inhibitor-resistant non-small-cell lung cancer cells to erlotinib in vitro and in vivo.
about
Inhibition of histone deacetylases sensitizes EGF receptor-TK inhibitor-resistant non-small-cell lung cancer cells to erlotinib in vitro and in vivo.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Inhibition of histone deacetyl ...... rlotinib in vitro and in vivo.
@en
Inhibition of histone deacetyl ...... rlotinib in vitro and in vivo.
@nl
type
label
Inhibition of histone deacetyl ...... rlotinib in vitro and in vivo.
@en
Inhibition of histone deacetyl ...... rlotinib in vitro and in vivo.
@nl
prefLabel
Inhibition of histone deacetyl ...... rlotinib in vitro and in vivo.
@en
Inhibition of histone deacetyl ...... rlotinib in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
Inhibition of histone deacetyl ...... rlotinib in vitro and in vivo.
@en
P2093
Feixiong Cheng
Guoliang Chen
Mingyao Liu
Yihua Chen
P2860
P304
P356
10.1111/BPH.13961
P407
P577
2017-07-27T00:00:00Z